SEC Form 4 · accession 0001073397-18-000016
ICU MEDICAL INC/DE · ICUI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George A Lopez
Director · 10% Owner
Period of report
Jul 5, 2018
Accepted (ET)
Jul 9, 2018 · 5:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000883984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 5, 2018 | S | 947 | $287.59 | D | 372,497 | D | |
| Common StockF3 | Jul 5, 2018 | S | 4,817 | $288.67 | D | 367,680 | D | |
| Common StockF4 | Jul 5, 2018 | S | 3,323 | $289.53 | D | 364,357 | D | |
| Common StockF5 | Jul 5, 2018 | S | 1,709 | $290.47 | D | 362,648 | D | |
| Common Stock | holding | — | — | — | 986,843 | I | by Partnership |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 27, 2017.
- F2The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $287.05 to 288.05, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F3The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $288.10 to 289.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F4The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $289.15 to 290.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F5The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $290.20 to 291.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.